PMHC – NEO / OZM-058
Trial Description:
A Phase II, Open-Label, Randomized, Multi-Centre Study of Neoadjuvant Olaparib in Patients with Platinum Sensitive Recurrent High Grade Serous Ovarian/Primary Peritoneal or Fallopian tube Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Closed to Recruitment
Contact person:
vbowering